# OrbusNeich Medical Company

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/orbusneich-medical-company

- Industry: Medical Devices & Equipment
- Headquarters: Hong Kong, Hong Kong SAR - China
- Website: www.orbusneich.com
- Total disclosed funding: $200M
- Latest round: Series B (Aug 30, 2021)
- Investors on record: 8

## About

Based in Hong Kong and founded in 2000 by Teddy Chien, OrbusNeich Medical Company Limited operates as a developer and manufacturer of medical devices that enable patients with cardiovascular diseases.  It has a distributor network covering over 70 countries and regions across six continents. In August 2020,  it acquired its distributor in Switzerland to expand its direct sales network. As of 2021, it has 500 employees.  In December 2022, it was listed on the Hong Kong Stock Exchange with stock code 06929.

The company's product lines include COMBO Plus and COMBO Dual Therapy Stents, Azule, Scoreflex, Scoreflex NC, Sapphire II, Sapphire II PRO, Sapphire 3, Sapphire NC Plus, Sapphire II NC, Sapphire NC24, Teleport and Teleport Control, as well as products to treat peripheral artery diseases such as Jade, Scoreflex PTA balloons, and Stealth 360.

## Funding rounds

- Series B, Aug 30, 2021, $200M — China International Capital Corporation, China Merchants Securities, Galaxy Capital, Shenzhen Capital Real Estate Fund, CCB International, Shenzhen Share Capital
- Series A, Jun 3, 2020 — China International Capital Corporation, Share Capital, China Merchants Zhiyuan Capital Investment

## Investors

- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series A, Series B
- Share Capital (https://capitalatlas.ai/funds/share-capital) — Series A
- China Merchants Zhiyuan Capital Investment — Series A
- China Merchants Securities — Series B
- Galaxy Capital (https://capitalatlas.ai/funds/galaxy-capital) — Series B
- Shenzhen Capital Real Estate Fund (https://capitalatlas.ai/funds/shenzhen-capital-real-estate-fund) — Series B
- CCB International (https://capitalatlas.ai/funds/ccb-international) — Series B
- Shenzhen Share Capital — Series B